Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-26Clinical Trial Update: GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery [Phase 1, Phase 2]
A two-phase clinical trial investigating GM-CSF, fosfomycin, and metronidazole for pouchitis in ulcerative colitis patients post-restorative…
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life
A national observational study assessing the real-world use of Inflectra (infliximab biosimilar) across multiple inflammatory diseases compl…
-
CLINICAL_TRIALS trial_result · 2023-01-18Clinical Trial Update: Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease
A completed clinical trial assessing healthcare resource use, mental health problems, and infections in people with inflammatory bowel disea…
-
CLINICAL_TRIALS trial_result · 2023-01-13Clinical Trial Update: Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis [Phase 1, Phase 2]
Clinical trial update for OST-122 in moderate to severe ulcerative colitis completed phases 1 and 2.
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 trial comparing etrasimod to placebo as induction therapy in moderately to severely active ulcerative colitis has completed with res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-20Clinical Trial Update: Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis [Phase 3]
A Phase 3 clinical trial comparing etrasimod to placebo in moderately to severely active ulcerative colitis has completed; results were post…
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: ISIS 2302-CS27, A 6-Week, Placebo-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis. [Phase 2]
Phase 2 trial evaluating Alicaforsen (ISIS 2302) vs placebo in mild to moderate active Ulcerative Colitis completed.
-
CLINICAL_TRIALS trial_result · 2022-12-05Clinical Trial Update: ISIS 2302-CS22, A 6-Week, Active-Controlled Clinical Study to Evaluate the Effectiveness of Alicaforsen (ISIS 2302) in Patients With Mild to Moderate Active Ulcerative Colitis [Phase 2]
Phase 2 trial investigating Alicaforsen (ISIS 2302) in mild to moderate active ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-25Clinical Trial Update: A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 maintenance trial results for mirikizumab in adults with moderately to severely active ulcerative colitis have been completed and po…
-
CLINICAL_TRIALS trial_result · 2022-11-22Clinical Trial Update: A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis. [Phase 2]
Phase II trial in adults with moderate to severe active ulcerative colitis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Efficacy & Safety of TD-1473 in Ulcerative Colitis [Phase 2, Phase 3]
Phase 2/3 trial of TD-1473 for ulcerative colitis was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD) [Phase 2]
Phase 2 clinical trial update for AMT-101 in ulcerative colitis; efficacy and safety data are not specified in the provided snippet.
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: Efficacy and Safety of Oral BT-11 in Ulcerative Colitis [Phase 2]
Phase 2 trial results for oral BT-11 in ulcerative colitis have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-11-02Clinical Trial Update: TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study [Phase 2, Phase 3]
Long-term safety study of TD-1473 in ulcerative colitis was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients [Phase 1, Phase 2]
Phase 1/2 trial updating on Lactobacillus rhamnosus GG (ATCC 53103) in patients with mild-to-moderate ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-09-14Clinical Trial Update: Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET) [Phase 2]
Phase 2 trial update on AMT-101 in combination with adalimumab in ulcerative colitis completed.
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis [Phase 2]
Phase 2 clinical trial evaluating tilpisertib for adults with moderately to severely active ulcerative colitis has been terminated; results …
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 trial comparing oral PF-06651600, PF-06700841, and placebo in moderate to severe ulcerative colitis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating safety and efficacy of deucravacitinib in moderate to severe ulcerative colitis has been completed with results pos…
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC) [Phase 2, Phase 3]
A study evaluating safety and efficacy of upadacitinib for induction and maintenance therapy in moderately to severely active ulcerative col…
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis [Phase 2]
A Phase 2 trial evaluating SER-287 for adults with active ulcerative colitis was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-02Clinical Trial Update: Outcomes Mandate National Integration With Cannabis as Medicine [Phase 2]
Phase 2 clinical trial update focusing on integrating cannabis as medicine for various chronic pain conditions, with status currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2022-06-01Clinical Trial Update: Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis [Phase 4]
Phase 4 clinical trial evaluating a Novel Diet (UC DIET) for treatment of mild to moderate active pediatric ulcerative colitis has completed…
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Saffron and Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial evaluating saffron for ulcerative colitis is underway, with unspecified status.
-
CLINICAL_TRIALS trial_result · 2022-05-09Clinical Trial Update: Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis [Phase 4]
Phase 4 trial comparing corticosteroids plus 5-aminosalicylic acid versus corticosteroids alone in moderate-severe ulcerative colitis.